Liver cancer is highly heterogeneous, and the
tumor tissue harbors a variety of cell types. Liver tumor initiating cells (
TICs) well contribute to
tumor heterogeneity and account for
tumor initiation and
metastasis, but the molecular mechanisms of liver
TIC self-renewal are elusive. Here, we identified a functional read-through rt-
circRNA, termed rtcisE2F, that is highly expressed in
liver cancer and liver
TICs. rtcisE2F plays essential roles in the self-renewal and activities of liver
TICs. rtcisE2F targets E2F6 and E2F3 mRNAs, attenuates
mRNA turnover, and increases E2F6/E2F3 expression. Mechanistically, rtcisE2F functions as a scaffold of
N-methyladenosine (
m6A) reader IGF2BP2 and E2F6/E2F3
mRNA. rtcisE2F promotes the association of E2F6/E2F3 mRNAs with IGF2BP2, and inhibits their association with another
m6A reader, YTHDF2. IGF2BP2 inhibits E2F6/E2F3 mRNA decay, whereas YTHDF2 promotes E2F6/E2F3 mRNA decay. By switching
m6A readers, rtcisE2F enhances E2F6/E2F3 mRNA stability. E2F6 and E2F3 are both required for liver
TIC self-renewal and Wnt/β-
catenin activation, and inhibition of these pathways is a potential strategy for preventing liver
tumorigenesis and
metastasis. In conclusion, the rtcisE2F-IGF2BP2/YTHDF2-E2F6/E2F3-Wnt/β-
catenin axis drives liver
TIC self-renewal and initiates liver
tumorigenesis and
metastasis, and may provide a strategy to eliminate liver
TICs.